Tamara Seitz - Infectious Diseases

Author Information

Tamara Seitz is affiliated with the 4th Medical Department specializing in Infectious Diseases and Tropical Medicine at the Kaiser-Franz-Josef Hospital in Vienna, Austria. Her work primarily focuses on the study and management of infectious diseases, with a particular emphasis on COVID-19 and related diagnostic and therapeutic strategies.

Research Contributions

Dr. Tamara Seitz has made significant contributions to the field of infectious diseases, particularly in the context of the COVID-19 pandemic. Her research encompasses the sensitivity and specificity of SARS-CoV-2 rapid antigen detection tests, the development of predictive models for COVID-19 patient mortality, and the evaluation of antiplatelet medication in COVID-19-related thrombotic complications. Additionally, she has explored the role of clinical science in pandemic response and has contributed to understanding the management of influenza and other infectious conditions.

Aliases

Dr. Tamara Seitz is also known by the names T Seitz and T. Seitz. These aliases are used in various publications and professional settings.

Publication and Citation Metrics

Metric	Value
Citation Count	1035
H-index	16
Paper Count	66

Publications:

Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study

DOI: 10.1128/spectrum.02029-21

Year: 2022

Evaluation of Five Commercial SARS-CoV-2 Antigen Tests in a Clinical Setting

DOI: 10.1007/s11606-022-07448-x

Year: 2022

A Rapid, Highly Sensitive and Open-Access SARS-CoV-2 Detection Assay for Laboratory and Home Testing

DOI: 10.3389/fmolb.2022.801309

Year: 2022

Whipple's disease diagnosed in a patient with suspected sarcoidosis.

DOI: 10.1016/j.ijid.2021.03.053

Year: 2021

A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation

DOI: 10.3389/fcimb.2021.795026

Year: 2021

The value of open-source clinical science in pandemic response: lessons from ISARIC

DOI: 10.1016/S1473-3099(21)00565-X

Year: 2021

Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications

DOI: 10.3389/fcvm.2021.802566

Year: 2021

Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5

DOI: 10.3389/fcvm.2021.779073

Year: 2021

Management of hospitalized influenza A patients during the season 2018/19

DOI: 10.1007/s00508-021-01950-8

Year: 2021

Successful treatment of intubation-induced severe neurogenic post-extubation dysphagia using pharyngeal electrical stimulation in a COVID-19 survivor: a case report

DOI: 10.1186/s13256-021-02763-z

Year: 2021

What Preventive Measures Can Be Taken?

How is Schistosomiasis Transmitted?

How should you prepare for medical emergencies abroad?

What are Antifungals?

Why is RT-PCR important in Infectious Diseases?

What are Some Natural Alternatives to Chemical Insect Repellents?

Why is it Important in Infectious Diseases?

What is a PCR Test?

How Does the Global Fund Work?

Why is Understanding Pathogenesis Important?

Partnered Content Networks

Relevant Topics